Clinical Trial Update: Study of Immune Response and Liver Damage Induced by Chemotherapy for Liver Metastases of Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial exploring immune response and chemotherapy-induced liver damage in patients with resectable hepatic metastases from colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Snippet

Sponsor: Poitiers University Hospital | Conditions: Resectable Hepatic Metastases of Colorectal Cancer | Phase 2 | Status: UNKNOWN